No Data
No Data
Cadrenal Therapeutics to Present at the Emerging Growth Conference on July 18, 2024
Cadrenal Therapeutics to Present at the Emerging Growth Conference on June 12, 2024
H.C. Wainwright Maintains Cadrenal Therapeutics(CVKD.US) With Buy Rating, Maintains Target Price $3
Cadrenal Therapeutics Highlights Presentation of New Trial Data at ISHLT Conference Demonstrating the Importance of Anticoagulation Quality in LVAD Patients
Cadrenal Therapeutics to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024
12 Health Care Stocks Moving In Monday's After-Market Session
No Data